Best in Biotech 10 May 2023
5 cell therapy companies you should know about
Cell therapy has come a long way in recent years, with many biotech companies now specializing in the development of…
Adaptimmune
- Latest Posts
Best in Biotech 17 Sep 2020
The Top 10 Biotech Companies Brewing at Oxford
Here are the top biotech companies in Oxford, a city with an old scientific tradition and an enormous output of…
News and Trends 15 Jan 2020
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese Astellas Pharma to complete phase…
Best in Biotech 21 May 2019
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way…
ADVERTISEMENT
Interview 11 Sep 2018
How To Break Into The Crowded Immuno-Oncology Space
The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in this crowded field, many companies…
News and Trends 9 Jan 2018
Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy
Following successful pilot studies, Adaptimmune will increase the dose of its T-cell therapy 10-fold to see if it remains safe,…
News and Trends 8 Sep 2017
GSK wants in on Adaptimmune’s Adaptable T cell Cancer Treatment
GSK has backed Adaptimmune in the development of their adaptable NY-ESO SPEAR T cell cancer therapy, causing an 11% jump…
Interview 20 Apr 2017
Which EU Immuno-Oncology Company are you Cheering for?
Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways…
Infographics 13 Feb 2017
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for its potential to cure cancer.…
News and Trends 23 Dec 2016
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry where failure is part of…
News and Trends 16 Nov 2016
Cell Therapies: Is Commercialization holding back a Breakthrough?
How far away is biotech from a breakthrough with cell and gene therapy? While these therapies have the potential to…
News and Trends 10 Nov 2016
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
The FDA puts one of Adaptimmune's TCR trials on a partial hold, pending more information about the production of its cell…
News and Trends 28 Oct 2016
TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some of the most promising technologies…
News and Trends 13 Oct 2016
Adaptimmune Revises TCR Protocol following Phase I/IIa Failure
Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked…
News and Trends 23 Feb 2016
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more depth; location, market cap and…
News and Trends 21 Dec 2015
Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round
Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO of Immunocore (and previously from…
ADVERTISEMENT
News and Trends 10 Dec 2015
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are the biotech companies in Europe…
News and Trends 9 Nov 2015
Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer
Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford's Adaptimmune has some surprisingly good…
News and Trends 15 Sep 2015
The 9 EU-based Billion-Euro Biotechs you Should (really) Know
Update 22/10/2015: I added Galapagos from Belgium and Basilea from Switzerland, they deserved it ... Talking about billon-dollar companies in…
News and Trends 3 Sep 2015
Adaptimmune Clinical Trials full-steam ahead with GSK investment!
Adaptimmune has had exciting results regarding the ongoing battle with Synovial Sarcoma. GSK looks to further invest in the expansion…
